Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Tract Infections 1Urinary Bladder Neoplasms 1Rectal Neoplasms 1Diverticulosis, Colonic 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Ertapenem × Clear all
NCT04502095 2025-08-03

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Roswell Park Cancer Institute

Phase 4 Completed
89 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urinary Tract Infections

NCT00535652 2017-02-10

Concentration of Ertapenem in Colorectal Tissue

University of Ulm

Phase 4 Completed
23 enrolled 5 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Diverticulosis, Colonic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡